The implementation of standards of care in Europe: State of the art

Journal of Cystic Fibrosis

Volumn 10, Issue SUPPL. 2, 2011, Pages

  Colombo, Carla ^a   Littlewood, James ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b CYSTIC FIBROSIS TRUST   (United Kingdom)

Author keywords

Care; Cystic fibrosis; Demographics

Indexed keywords

ANTIBIOTIC AGENT;

ARTICLE; CYSTIC FIBROSIS; DISEASE REGISTRY; EARLY DIAGNOSIS; ENZYME THERAPY; EUROPE; FUNDING; GENERAL CONDITION; GROWTH DISORDER; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HUMAN; INCIDENCE; INFORMATION PROCESSING; LUNG FUNCTION; MALNUTRITION; MANAGEMENT; MEDICAL DOCUMENTATION; MEDICAL EXAMINATION; MEDICAL SERVICE; NEWBORN SCREENING; NUTRITIONAL SUPPORT; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT MONITORING; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; PUBLICATION; RESPIRATORY TRACT INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TREATMENT DURATION;

COOPERATIVE BEHAVIOR; CYSTIC FIBROSIS; DELIVERY OF HEALTH CARE; EUROPE; HUMANS; QUALITY OF HEALTH CARE; REGISTRIES;

EID: 79958176941     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/S1569-1993(11)60003-9     Document Type: Article

References (48)

1. Valerius NH, Koch C, Hoiby N Prevention of chronic Pseudomonas aeruginosa infection in cystic fibrosis by early treatment. Lancet 1991, 338:725-726.
2. Frederikson B, Lanng S, Koch C, Høiby N Improved survival in the Danish center-treated cystic fibrosis patients: results of aggressive treatment. Pediatr Pulmonol 1996, 21:153-158.
3. Lebecque P, Leal T, Zylberberg K, Reychler G, Bossuyt X, Godding V Towards zero prevalence of chronic Pseudomonas aeruginosa infection in children with cystic fibrosis. J Cyst Fibros 2006, 5:237-244.
4. Farrell PM, Kosorok MR, Rock MJ, et al. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Pediatrics 2001, 107:1-13.
5. Castellani C, Southern KW, Brownlee K, et al. European best practice guidelines for cystic fibrosis neonatal screening. J Cyst Fibros 2009, 8:153-173.
6. Cystic Fibrosis Foundation Clinical Practice Guidelines for Cystic Fibrosis 1997, Cystic Fibrosis Foundation, Bethesda, MD.
7. Mahadeva R, Webb K, Westerbeek RC, Carroll NR, Dodd ME, Bilton D Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study. BMJ 1998, 316:1771-1775.
8. Standards for the clinical care of children and adults with cystic fibrosis in the UK Cystic Fibrosis Trust Clinical Standards and Accreditation Group 2001, Cystic Fibrosis Trust, London.
9. Kerem E, Conway S, Elborn S, Heijerman H, for the Consensus Committee Standards of care for patients with cystic fibrosis: A European consensus. J Cyst Fibros 2005, 4:7-26.
10. Sims EJ, Clark A, McCormick J, Mehta G, Connett G, Mehta A Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy. Pediatrics 2007, 119:19-28.
11. Sims EJ, McCormick J, Mehta G, Mehta A Newborn screening for cystic fibrosis is associated with reduced treatment intensity. J Pediatr 2005, 147:306-311.
12. Padman R, McColley SA, Miller DP, et al. Investigators and coordinators of the epidemiologic study of cystic fibrosis. Infant care patterns at epidemiologic study of cystic fibrosis sites that achieve superior childhood lung function. Pediatrics 2007, 119:531-537.
13. Cheng K, Smyth RL, Motley J, O'Hea U, Ashby D Randomized controlled trials in cystic fibrosis (1966-1997) categorized by time, design, and intervention. Pediatr Pulmonol 2000, 29:1-7.
14. Briggs TA, Bryant M, Smyth RL Controlled clinical trials in cystic fibrosis - are we doing better?. J Cyst Fibros 2006, 5:3-8.
15. Cystic Fibrosis Foundation Guidelines for Patient Services, Evaluation, and Monitoring in Cystic Fibrosis Centers Cystic Fibrosis Foundation Center Committee and Guidelines Cystic Fibrosis Foundation Subcommittee. Am J Dis Child 1990, 144:1311-1312.
16. Döring G, Conway SP, Heijerman HG, et al. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J 2000, 16:749-767.
17. Döring G, Høiby N, for the Consensus Study Group Early intervention and prevention of lung disease in cystic fibrosis: a European consensus. J Cyst Fibros 2004, 3:67-91.
18. Sinaasappel M, Stern M, Littlewood J, et al. Nutrition in patients with cystic fibrosis: a European Consensus. J Cyst Fibros 2002, 1:51-75.
19. Malfroot A, Adam G, Ciofu O, et al. Immunisation in the current management of cystic fibrosis patients. J Cyst Fibros 2005, 4:77-87.
20. Edenborough FP, Borgo C, Knoop C, et al. Guidelines for the management of pregnancy in women with cystic fibrosis. J Cyst Fibros 2008, 7(Suppl 1):S1-32.
21. Castellani C, Cuppens H, Macek M Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros 2008, 7:179-196.
22. Mayell SJ, Munck A, Craig JV, et al. A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis. On behalf of the European Cystic Fibrosis Society Neonatal Screening Working Group. J Cyst Fibros 2009, 8:71-78.
23. Elborn JS, Hodson M, Bertram C Implementation of European standards of care for cystic fibrosis - provision of care. J Cyst Fibros 2009, 8:348-355.
24. Elborn JS, Hodson ME, Bertram C Implementation of standards of care for cystic fibrosis - control and treatment of infection. J Cyst Fibros 2009, 8:211-217.
25. Phelan P, Hey E Cystic fibrosis mortality in England and Wales and Victoria Australia. Arch Dis Child 1984, 59:71-73.
26. Wood RE, Piazza F Survival in cystic fibrosis: correlation with treatment in three cystic fibrosis centers. 10th International Cystic Fibrosis Congress, Sydney. Excerpta Medica Asia Pacific Services 1988, 74:89.
27. Corey M, McLaughlin FJ, Williams M, Levison H A comparison of survival growth and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 1988, 41:588-591.
28. UK Cystic Fibrosis Trust CF Patient Registry http://www.cftrust.org.uk.
29. US Cystic Fibrosis Foundation Patient Registry http://www.cff.org.
30. Quinton H Using data to identify opportunities for change and to monitor progress. Pediatr Pulmonol Suppl 2004, 27:124-125.
31. Quinton HB O'Connor GT. Current issues in quality improvement in cystic fibrosis. Clin Chest Med 2007, 28:459-472.
32. Warwick WJ, Manson S. Life table studies of mortality. In: Rossi E, Stoll E (eds.). Cystic Fibrosis Part I. Physiology and pathophysiology of serum secretion clinical investigation and therapy. Proc 4th Int Conf on CF. Geigy Symposium Berne/Grundewald 1966 (Modern Problems in Pediatrics Vol 10). Karger: Basle and New York; p. 353.
33. Nielsen OH, Schoitz O Cystic fibrosis in Denmark in the period 1945-1981. Evaluation of centralized treatment. Acta Paediatr Scand Suppl 1982, 301:107-119.
34. Vasquez Cordero C, Idigoras Ayastuy G, Galardi Andonegui MS, et al. Survival rates of children with cystic fibrosis. Anales Espanoles de Pediatria 1990, 32:407-412.
35. Merelle ME, Schouten JP, Gerritsen J, Dankert-Roelse JE Influence of neonatal screening and centralized treatment on long-term clinical outcome and survival in CF patients. Eur Resp J 2001, 18:306-315.
36. Lebecque P, Leonard A, De Boeck K, et al. Early referral to cystic fibrosis specialist centre impacts on respiratory outcome. J Cyst Fibros 2009, 8:26-30.
37. Stern M, Wiedemann B, Wenzlaff P German Cystic Fibrosis Quality Assessment Group. From registry to quality management: the German Cystic Fibrosis Quality Assessment project 1995-2006. Eur Respir J 2008, 31:29-35.
38. Bilton D, MacNeill SJ, Cullinan P, Larsen A Cystic fibrosis in the UK: A review of the 2007 data. Pediatr Pulmonol Suppl 2009, 32:378.
39. Mei-Zahay M, Yahav Y, Kerem E, et al. The Israeli cystic fibrosis database - genetic and clinical characteristics. Pediatr Pulmonol Suppl 2009, 32:378.
40. Lindblad A, Hjelte L, Mared L, et al. Differences in treatment and outcome between the USA and Sweden. Pediatr Pulmonol Suppl 2009, 32:376.
41. Gunn E, Osmond J, Baker M, Larsen A, Bilton D A costing and severity banding exercise in patients with cystic fibrosis in the UK for 2007 and 2008. Pediatr Pulmonol Suppl 2009, 32:394.
42. Buzzetti R, Salvatore D, Baldo E, et al. An overview of international literature from cystic fibrosis registries: 1. Mortality and survival studies in cystic fibrosis. J Cyst Fibros 2009, 8:229-237.
43. McCormick J, Mehta G, Olesen HV, Viviani L, Macek M, Mehta A, European Registry Working Group Comparative demographics of the European cystic fibrosis population: a cross sectional database analysis. Lancet 2010, 375:1007-1013.
44. Farrell PM The prevalence of cystic fibrosis in the European Union. J Cyst Fibros 2008, 7:450-453.
45. Bobadilla JL, Macek M, Fine JP, Farrell PM Cystic fibrosis: A worldwide analysis of CFTR mutations - Correlation with incidence data and application to screening. Hum Mutat 2002, 19:575-606.
46. Kahre D. Personal communication, 2010.
47. Chatfield S, Owen G, Ryley HC, et al. Neonatal screening for cystic fibrosis in Wales and the West Midlands: clinical assessment after five years of screening. Arch Dis Child 1991, 66:29-33.
48. Sly PD, Brennan S, Gangell C, et al. Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening. Am J Resp Crit Care 2009, 180:146-152.